doi: 10.1128/AAC.35.4.773.
Susceptibilities of Mycobacterium fortuitum biovar. fortuitum and the two subgroups of Mycobacterium chelonae to imipenem, cefmetazole, cefoxitin, and amoxicillin-clavulanic acid
Affiliations
- PMID: 2069387
- PMCID: PMC245098
- DOI: 10.1128/AAC.35.4.773
Item in Clipboard
Susceptibilities of Mycobacterium fortuitum biovar. fortuitum and the two subgroups of Mycobacterium chelonae to imipenem, cefmetazole, cefoxitin, and amoxicillin-clavulanic acid
Antimicrob Agents Chemother.
1991 Apr.
Abstract
MICs of imipenem, cefoxitin, cefmetazole, and amoxicillin-clavulanic acid were determined against 100 strains of Mycobacterium fortuitum and 200 strains of Mycobacterium chelonae. Imipenem and cefmetazole were more active against M. fortuitum than cefoxitin was, and imipenem (which inhibited 39% of strains at 8 micrograms/ml) was the only beta-lactam active against M. chelonae subsp. chelonae.
Similar articles
-
Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. centers.Antimicrob Agents Chemother. 1990 Aug;34(8):1546-50. doi: 10.1128/AAC.34.8.1546. Antimicrob Agents Chemother. 1990. PMID: 2221864 Free PMC article.
-
Susceptibilities of nontuberculosis mycobacterial species to amoxicillin-clavulanic acid alone and in combination with antimycobacterial agents.Antimicrob Agents Chemother. 1995 Jul;39(7):1454-7. doi: 10.1128/AAC.39.7.1454. Antimicrob Agents Chemother. 1995. PMID: 7492084 Free PMC article.
-
Susceptibility of Bacteroides non-fragilis and fusobacteria to amoxicillin, amoxicillin/clavulanate, ticarcillin, ticarcillin/clavulanate, cefoxitin, imipenem and metronidazole.Eur J Clin Microbiol Infect Dis. 1990 Jun;9(6):417-21. doi: 10.1007/BF01979473. Eur J Clin Microbiol Infect Dis. 1990. PMID: 2387295
-
Beta-lactamase production, beta-lactam sensitivity and resistance to synergy with clavulanate of 737 Bacteroides fragilis group organisms from thirty-three US centres.J Antimicrob Chemother. 1990 Sep;26(3):361-70. doi: 10.1093/jac/26.3.361. J Antimicrob Chemother. 1990. PMID: 2228827
-
In vitro susceptibility of Mycobacterium fortuitum to amoxicillin or cephalothin in combination with clavulanic acid.Antimicrob Agents Chemother. 1983 Jun;23(6):935-7. doi: 10.1128/AAC.23.6.935. Antimicrob Agents Chemother. 1983. PMID: 6604496 Free PMC article.
Cited by
-
Antibiotic Susceptibility of Mycobacteria Isolated from Ornamental Fish.J Vet Res. 2022 Mar 25;66(1):69-76. doi: 10.2478/jvetres-2022-0011. eCollection 2022 Mar. J Vet Res. 2022. PMID: 35582485 Free PMC article.
-
Clinical experience in 52 patients with tigecycline-containing regimens for salvage treatment of Mycobacterium abscessus and Mycobacterium chelonae infections.J Antimicrob Chemother. 2014 Jul;69(7):1945-53. doi: 10.1093/jac/dku062. Epub 2014 Mar 14. J Antimicrob Chemother. 2014. PMID: 24633206 Free PMC article. Clinical Trial.
-
Approach to the diagnosis and treatment of non-tuberculous mycobacterial disease.J Clin Tuberc Other Mycobact Dis. 2021 May 8;24:100244. doi: 10.1016/j.jctube.2021.100244. eCollection 2021 Aug. J Clin Tuberc Other Mycobact Dis. 2021. PMID: 34036184 Free PMC article.
-
Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria.Clin Microbiol Rev. 2002 Oct;15(4):716-46. doi: 10.1128/CMR.15.4.716-746.2002. Clin Microbiol Rev. 2002. PMID: 12364376 Free PMC article. Review.
-
Clinical and radiological features of pulmonary disease caused by rapidly growing mycobacteria in cancer patients.Eur J Clin Microbiol Infect Dis. 1998 Sep;17(9):615-21. doi: 10.1007/BF01708343. Eur J Clin Microbiol Infect Dis. 1998. PMID: 9832262
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
